OR WAIT null SECS
March 17, 2023
Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.
Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.
March 15, 2023
Organizations can better understand the maturity of AI-driven automation technology across their organization’s IT landscape through effective pharmacovigilance.
March 09, 2023
Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies.
Vetter has become a participant of the UN Global Compact Network.
March 08, 2023
Actylis new 30,000-ft² API manufacturing facility is located in Eugene, Ore.
February 27, 2023
Bio-Rad’s newly launched StarBright Blue and StarBright Yellow dyes are intended for use in various flow cytometry applications.
Eurofins Viracor ExPeCT CAR-T qPCR assay is a tool designed for monitoring and optimizating CAR-T therapies.
February 22, 2023
Agilent’s therapeutic nucleic acids facility gains architectural design support from CRB.
Quotient Sciences’ facility expansion is designed to increase support for fully integrated drug development programs.